It’s tough to find a great comedy these days, and even tougher to find one that isn’t a downer. Lately, it feels like ...

Strategic collaborations with partners such as Bristol-Myers Squibb and Genentech are intended to accelerate progress. While the pipeline is broadening, management notes that none of the oncology ...

MUMBAI: With as many as 12 newly elected BMC corporators belonging to Gen Z—aged under 30—the new House is set to get a ...

Bispecific antibodies are one of the hottest areas for drug research and dealmaking, and several of them were discussed this ...

Find a portion of our conversation below, which covers Broussard’s decision to leave Humana and his thoughts on how AI could affect health care companies’ brand reputations. Editor’s Note: Transcript ...

The hemophagocytic lymphohistiocytosis market is expected to increase due to the launch of emerging therapies, such as plonmarlimab (TJ Biopharma), ELA026 (Electra Therapeutics), MAS825 (Novartis) ...

DelveInsight's Hemophagocytic Lymphohistiocytosis Market Insights report includes a comprehensive understanding of current treatment practices, hemophagocytic lymphohistiocytosis emerging drugs, ...

The application process for the Common University Entrance Test (CUET) UG 2026 is underway. The National Testing Agency (NTA) ...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he ...

The State Common Entrance Test Cell, Mumbai, has officially started the registration process for the MAH CET 2026 for ...

The current state of radiotherapeutics is “the isotope wars”, according to Jack Hoppin, CEO of Boston’s Ratio Therapeutics.

Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...